Advertisement
Research Article Free access | 10.1172/JCI106610
Department of Medicine, Columbia University College of Physicians and Surgeons, New York 10032
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215
Gastrointestinal Unit of the Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215
Find articles by Kimberg, D. in: JCI | PubMed | Google Scholar
Department of Medicine, Columbia University College of Physicians and Surgeons, New York 10032
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215
Gastrointestinal Unit of the Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215
Find articles by Baerg, R. in: JCI | PubMed | Google Scholar
Department of Medicine, Columbia University College of Physicians and Surgeons, New York 10032
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215
Gastrointestinal Unit of the Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215
Find articles by Gershon, E. in: JCI | PubMed | Google Scholar
Department of Medicine, Columbia University College of Physicians and Surgeons, New York 10032
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215
Gastrointestinal Unit of the Department of Medicine, Beth Israel Hospital, Boston, Massachusetts 02215
Find articles by Graudusius, R. in: JCI | PubMed | Google Scholar
Published June 1, 1971 - More info
It is generally recognized that glucocorticoid administration may diminish calcium absorption in vivo as well as the active transport of calcium by the intestine in vitro. Recent studies by others have emphasized the possibility of an alteration in the metabolism of vitamin D to 25-hydroxycholecalciferol in accounting for the steroid effects on calcium absorption. The results obtained in the present studies fail to support this hypothesis.
The present studies confirm that the administration of cortisone or other glucocorticoids to the rat interferes with the active transport of calcium by duodenal gut sacs in vitro. This abnormality is not due to an alteration in the permeability of the intestine to calcium, and it cannot be corrected by the administration of either massive doses of vitamin D2 or modest doses of 25-hydroxycholecalciferol. Experiments concerned with the effects of cortisone on the level of the vitamin D-dependent duodenal calcium-binding protein, the amount of bioassayable vitamin D activity in the mucosa, and the distribution and metabolism of 3H-vitamin D3, did not provide evidence in favor of a harmone-related defect in either the localization of vitamin D or its metabolism to 25-hydroxycholecalciferol. Alterations in the transport of iron and D-galactose, not dependent on vitamin D, suggest that cortisone treatment may be responsible for more than a simple antagonism to the effects of vitamin D.
The results of the present studies indicate that cortisone administration affects the cellular mechanisms mediating calcium transport in a manner that is opposite to the effects of vitamin D, but seems to be independent of any direct interaction with the parent vitamin or its metabolites. If a disorder in vitamin D metabolism is at all involved, it is at a step subsequent to 25-hydroxylation.